Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Dilution, Not Bankruptcy, Is the Key Risk Facing Aurora Cannabis Stock

By Vince Martin, InvestorPlace Contributor
Aurora stock continues to fall, and its risk seems to be accelerating. But the imminent risk is more issuance of ACB stock, not bankruptcy.

Expect More Dilution, Debt, Deficits, and a Deep Drop in ACB Stock

By Mark R. Hake, CFA
Expect more dilution, debt, deficits, and a deep drop in Aurora stock. Aurora Cannabis free cash flow losses will require more debt and dilution.

Best ETFs for 2020: The Alternative Harvest ETF (MJ) Will Light Up

By Tim Biggam, InvestorPlace Contributor
The Alternative Harvest ETF (MJ) has a shot at being one of the best ETFs next year, as its holdings should bounce off their all-time lows.

3 Excellent Reasons to Be Bullish on Aphria

By Tom Taulli, InvestorPlace Contributor
It’s been horrific for cannabis stocks. But Aphria stock is presenting some interesting opportunities. Here’s a look at this standout company.

Hexo? Heck No! Just Avoid Hexo Stock for Now

By David Moadel, InvestorPlace Contributor
I'm still bullish on marijuana stocks, but I won't let Hexo stock weigh down my portfolio.

Tuesday’s Vital Data: Freeport-McMoRan, Canopy Growth and Aurora Cannabis

By Tyler Craig, Tales of a Technician
Options trading was buzzing in Freeport-McMoRan, Canopy Growth and Aurora Cannabis. Here are the metrics that matter moving forward.

Aphria Is Making the Right Moves to Survive Marijuana Slump

By Ian Bezek, InvestorPlace Contributor
The outlook for cannabis stocks remains challenging. But if anyone can turn it around in 2020, it could well be Aphria.

If You Haven’t Ditched NBEV Stock Yet, Now Is the Time

By Mark R. Hake, CFA
New Age Beverages stock is a multi-level marketing loser. The CEO is selling shares and the company is in debt and losing money.

5 Reasons to Buy Aphria Stock Before Pot Stocks Start Moving Again

By Wayne Duggan, InvestorPlace Contributor
Like other Canadian cannabis stocks, APHA stock has taken a beating in recent months as revenue growth has fallen short of expectations. However, there are at least five reasons why Aphria shares could be headed higher soon.

Is the Right Move to Buy Hexo Stock Amid Cannabis Rebound?

By Bret Kenwell, InvestorPlace Contributor
Hexo stock is showing improvement on the charts, but we need a significant improvement given the lacking fundamentals and industry disdain.

Cannabis 2.0 Highlights the Rewards — and Risks — of Canopy Growth Stock

By Vince Martin, InvestorPlace Contributor
Cannabis 2.0 is supposed to give Canopy Growth stock an edge over other cannabis plays. But if Cannabis 2.0 is disappointing, CGC stock will be out of catalysts.

7 Lumbering Large-Cap Stocks to Avoid

By Louis Navellier, Editor, Growth Investor
The U.S.-China trade war is weighing on these large-cap stocks to sell. Volatile oil prices and the opioid crisis aren't helping, either.

The Outlook of Aurora Stock Is Mixed

By Chris Lau, InvestorPlace Contributor
Aurora stock is out of favor and is at risk of falling steadily over the next few quarters. But the long-term outlook of ACB stock is upbeat.

10 Hot Pot Stocks to Buy

By Josh Enomoto, InvestorPlace Contributor
When pot stocks failed to live up to heightened expectations, investors panicked out of the sector. However, the selloff has probably gone on far too long, suggesting a possible comeback.

A Constellation Buyout Would Harm Canopy Growth Shareholders

By Will Healy, InvestorPlace Contributor
Canopy Growth, like other marijuana stocks, continues trending downward. One big factor could prevent it from recovering.

Why Canopy Growth Stock Could Rebound Tremendously in 2020

By Luke Lango, InvestorPlace Senior Investment Analyst
While 2019 was a rough year for Canopy Growth stock, CGC stock could nearly double in 2020.

Aurora Cannabis Stock Offers Traders Fresh Opportunities

By Nicolas Chahine, InvestorPlace Contributor
Cannabis stocks are struggling to gain traction but trading opportunities are still available. Aurora stock wants to base to setup rallies.

5 Under-the-Radar Marijuana Stocks With Over 100% Upside

By Maya Sasson, Writer, TipRanks
With the U.S. taking one step closer towards decriminalization, I set out to find marijuana stocks that have been flying under the radar.

What the MORE Act Means for Cannabis Stocks

By Wayne Duggan, InvestorPlace Contributor
The MORE Act is one of two marijuana bills making their way through Congress. The MORE Act is good news for the legalization effort, but it likely won't be a game-changer for cannabis stocks.
Load More